| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
2B-Adrenergic Receptor That Is Associated with Reduced Basal Metabolic Rate in Obese Subjects
Department of Pharmacology and Clinical Pharmacology, University of Turku (P.H., M.K., U.P., M.K.K., M.S.), FIN-20520 Turku; the Eating Disorder Unit, University Hospital of Helsinki (A.R.), FIN-00250 Helsinki; and the Departments of Medicine (M.L.) and Clinical Nutrition (R.V., M.U.), University of Kuopio, FIN-70211 Kuopio, Finland
Address all correspondence and requests for reprints to: Dr. Markku Koulu, Department of Pharmacology and Clinical Pharmacology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland. E-mail: markku.koulu{at}utu.fi
The
2-adrenergic receptors mediate part of the actions
of the catecholamines noradrenaline and adrenaline on the regulation of
energy balance. As part of an ongoing study on the genetics of obesity,
the entire coding sequence of the
2B-adrenoceptor gene
was screened in 58 obese, nondiabetic Finns by PCR-single stranded
conformational analysis (PCR-SSCA). A polymorphism that leads to a
deletion of 3 glutamic acids from a glutamic acid repeat element
(Glu x 12, amino acids 297309) present in the third
intracellular loop of the receptor protein was identified. This repeat
element has previously been shown to be important for agonist-dependent
receptor desensitization. Of 166 genotyped subjects, 47 (28%) had 2
normal (long) alleles (Glu12/Glu12), 90 (54%)
were heterozygous (Glu12/Glu9), and 29 (17%)
were homozygous for the short (Glu9/Glu9) form.
The basal metabolic rate, determined by indirect calorimetry and
adjusted for fat-free body mass, fat mass, sex, and age, was 94 Cal/day
(5.6%) lower (95% confidence interval for difference, 32, 156)
in subjects homozygous for the short allele than in subjects with two
long alleles (F = 4.84; P = 0.009, by ANOVA).
Thus, a genetic polymorphism of the
2B-adrenoceptor
subtype can partly explain the variation in basal metabolic rate in an
obese population and may therefore contribute to the pathogenesis of
obesity.
This article has been cited by other articles:
![]() |
S. L. Kirstein and P. A. Insel Autonomic Nervous System Pharmacogenomics: A Progress Report Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. von Wowern, K. Bengtsson, U. Lindblad, L. Rastam, and O. Melander Functional Variant in the {alpha}2B Adrenoceptor Gene, a Positional Candidate on Chromosome 2, Associates With Hypertension Hypertension, March 1, 2004; 43(3): 592 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Ruuskanen, H. Xhaard, A. Marjamaki, E. Salaneck, T. Salminen, Y.-L. Yan, J. H. Postlethwait, M. S. Johnson, D. Larhammar, and M. Scheinin Identification of Duplicated Fourth {alpha}2-Adrenergic Receptor Subtype by Cloning and Mapping of Five Receptor Genes in Zebrafish Mol. Biol. Evol., January 1, 2004; 21(1): 14 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suzuki, T. Matsunaga, K. Nagasumi, T. Yamamura, N. Shihara, T. Moritani, H. Ue, M. Fukushima, A. Tamon, Y. Seino, et al. {alpha}2B-Adrenergic Receptor Deletion Polymorphism Associates with Autonomic Nervous System Activity in Young Healthy Japanese J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1184 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Snapir, J. Mikkelsson, M. Perola, A. Penttila, M. Scheinin, and P. J. Karhunen Variation in the alpha2B-adrenoceptorgene as a risk factor for prehospitalfatal myocardial infarction and sudden cardiac death J. Am. Coll. Cardiol., January 15, 2003; 41(2): 190 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Madsen, D. Willemsen, B. M. Ursing, U. Arnason, and W. W. de Jong Molecular Evolution of the Mammalian Alpha 2B Adrenergic Receptor Mol. Biol. Evol., December 1, 2002; 19(12): 2150 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Snapir, P. Heinonen, T.-P. Tuomainen, P. Alhopuro, M. K. Karvonen, T. A. Lakka, K. Nyyssonen, R. Salonen, J. Kauhanen, V.-P. Valkonen, et al. An insertion/deletion polymorphism in the {alpha}2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1516 - 1522. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Poirier, V. Nicaud, N. Vionnet, S. Raoux, L. Tarnow, H. Vlassara, H.-H. Parving, and F. Cambien Polymorphism Screening of Four Genes Encoding Advanced Glycation End-Product Putative Receptors: Association Study With Nephropathy in Type 1 Diabetic Patients Diabetes, May 1, 2001; 50(5): 1214 - 1218. [Abstract] [Full Text] |
||||
![]() |
I. J. Dionne, A. N. Turner, A. Tchernof, T. I. Pollin, D. Avrithi, D. Gray, A. R. Shuldiner, and E. T. Poehlman Identification of an Interactive Effect of {beta}3- and {alpha}2b-Adrenoceptor Gene Polymorphisms on Fat Mass in Caucasian Women Diabetes, January 1, 2001; 50(1): 91 - 95. [Abstract] [Full Text] |
||||
![]() |
K. M. Small, K. M. Brown, S. L. Forbes, and S. B. Liggett Polymorphic Deletion of Three Intracellular Acidic Residues of the alpha 2B-Adrenergic Receptor Decreases G Protein-coupled Receptor Kinase-mediated Phosphorylation and Desensitization J. Biol. Chem., February 9, 2001; 276(7): 4917 - 4922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |